Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China

The Lancet Gastroenterology and Hepatology

Volumn 1, Issue 4, 2016, Pages 307-316

  Kaplan, Gilaad G ^a   Ng, Siew C ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHINA; CROHN DISEASE; ECONOMIC DEVELOPMENT; HUMAN; INFLAMMATORY BOWEL DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ULCERATIVE COLITIS; UNITED KINGDOM; GLOBAL HEALTH; HISTORY; INCIDENCE; INTERNATIONAL COOPERATION;

CHINA; GLOBAL HEALTH; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; INTERNATIONALITY; RISK FACTORS; UNITED KINGDOM;

EID: 84996560225     PISSN: 24681253     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2468-1253(16)30077-2     Document Type: Review

References (90)

1. 1 Xavier, RJ, Podolsky, DK, Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007), 427–434.
2. 2 Liu, JZ, van Sommeren, S, Huang, H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47 (2015), 979–986.
3. 3 Jostins, L, Ripke, S, Weersma, RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
4. 4 Ananthakrishnan, AN, Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci 60 (2014), 290–298.
5. 5 Frolkis, A, Dieleman, LA, Barkema, H, et al. Environment and the inflammatory bowel diseases. Can J Gastroenterol 27 (2013), e18–e24.
6. 6 Kaplan, GG, The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 12 (2015), 720–727.
7. 7 Mulder, DJ, Noble, AJ, Justinich, CJ, Duffin, JM, A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis 8 (2014), 341–348.
8. 8 Molodecky, NA, Soon, IS, Rabi, DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (2012), 46–54.
9. 9 Zhao, J, Ng, SC, Lei, Y, et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of “western” disease. Inflamm Bowel Dis 19 (2013), 1839–1845.
10. 10 Ng, SC, Emerging leadership lecture: inflammatory bowel disease in Asia: emergence of a “Western” disease. J Gastroenterol Hepatol 30 (2014), 440–445.
11. 11 Wilks, S, Moxon, W, Lectures on pathological anatomy, 2nd edn., 1875, J&A Churchill, London.
12. 12 Crohn, BB, Ginzburg, L, Oppenheimer, GD, Regional ileitis: a pathologic and clinical entity. JAMA 99 (1932), 1323–1329.
13. 13 Kirsner, JB, Historical aspects of inflammatory bowel disease. J Clin Gastroenterol 10 (1988), 286–297.
14. 14 Kirsner, JB, Historical origins of current IBD concepts. World J Gastroenterol 7 (2001), 175–184.
15. 15 Crafts, N, Productivity growth in the industrial revolution: a new growth accounting perspective. J Econ Hist 64 (2004), 521–535.
16. 16 Baron, JH, Inflammatory bowel disease up to 1932. Mt Sinai J Med 67 (2000), 174–189.
17. 17 Banerjee, AK, Sir Samuel Wilks: a founding father of clinical science. J R Soc Med 84 (1991), 44–45.
18. 18 Fielding, JF, Crohn's disease and Dalziel's syndrome: a history. J Clin Gastroenterol 10 (1988), 279–285.
19. 19 Abercrombie, J, Pathological and practical researches on diseases of the stomach, the intestinal canal, the liver and other viscera of the abdomen, 1830, Carey and Lea, Philadelphia.
20. 20 Fielding, JH, Crohn's disease in London in the latter half of the nineteenth century. Ir J Med Sci 153 (1984), 214–220.
21. 21 Walker, JF, Fielding, JF, Crohn's disease in Dublin in the latter half of the nineteenth century. Ir J Med Sci 157 (1988), 235–237.
22. 22 Allchin, WH, A discussion on “ulcerative colitis”: introductory address. Proc R Soc Med 2 (1909), 59–75.
23. 23 Mayberry, J, Rhodes, J, Hughes, LE, Incidence of Crohn's disease in Cardiff between 1934–1977. Gut 20 (1979), 602–608.
24. 24 Gunesh, S, Thomas, GA, Williams, GT, Roberts, A, Hawthorne, AB, The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996–2005. Aliment Pharmacol Ther 27 (2008), 211–219.
25. 25 Yapp, TR, Stenson, R, Thomas, GA, Lawrie, BW, Williams, GT, Hawthorne, AB, Crohn's disease incidence in Cardiff from 1930: an update for 1991–1995. Eur J Gastroenterol Hepatol 12 (2000), 907–911.
26. 26 Thomas, GA, Millar-Jones, D, Rhodes, J, Roberts, GM, Williams, GT, Mayberry, JF, Incidence of Crohn's disease in Cardiff over 60 years: 1986–1990 an update. Eur J Gastroenterol Hepatol 7 (1995), 401–405.
27. 27 Stone, MA, Mayberry, JF, Baker, R, Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol 15 (2003), 1275–1280.
28. 28 Burisch, J, Jess, T, Martinato, M, Lakatos, PL, The burden of inflammatory bowel disease in Europe. J Crohns Colitis 7 (2013), 322–337.
29. 29 Ouyang, Q, Tandon, R, Goh, K-L, Ooi, CJ, Ogata, H, Fiocchi, C, The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 21 (2005), 408–413.
30. 30 Jiang, X, Wang, Z, Qin, C, Current research status and strategy on ulcerative colitis in China. World Chin J Digestol 8 (2000), 610–613.
31. 31 Jiang, X-L, Cui, H-F, An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 8 (2002), 158–161.
32. 32 Yang, H, Li, Y, Wu, W, et al. The incidence of inflammatory bowel disease in northern China: a prospective population-based study. PLoS One, 9, 2014, e101296.
33. 33 Zeng, Z, Zhu, Z, Yang, Y, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol 28 (2013), 1148–1153.
34. 34 Jiang, X, Quan, Q, Wang, Z, Diagnosis and treatment of ulcerative colitis. World Chin J Digestol 8 (2000), 332–342 (in Chinese).
35. 35 Hu, R, Ouyang, Q, Chen, X, Analysis of the articles of inflammatory bowel disease in the literature China in recent fifteen years. Chin J Gastroenterol, 12, 2007, 74 (in Chinese).
36. 36 Wang, YF, Ouyang, Q, Hu, RW, Progression of inflammatory bowel disease in China. J Dig Dis 11 (2010), 76–82.
37. 37 Ouyang, Q, Xue, LY, Inflammatory bowel disease in the 21st century in China: turning challenges into opportunities. J Dig Dis 13 (2012), 195–199.
38. 38 Ouyang, Q, Survey and outlook on inflammatory bowel diseases in our country. Chin J Dig 13 (1993), 313–314 (in Chinese).
39. 39 Zhang, J, Zhou, D, Zhang, S, Wu, X, Bei, L, Summary account to national symposium on chronic diarrhea. Chin J Dig 7 (1987), 159–162 (in Chinese).
40. 40 Zheng, JJ, Zhu, XS, Huangfu, Z, Gao, ZX, Guo, ZR, Wang, Z, Crohn's disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis 6 (2005), 175–181.
41. 41 APDW2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: nationwide study from 1990 to 2003. J Gastroenterol Hepatol 21 (2006), 1009–1015.
42. 42 Ng, S, Kaplan, GG, Banerjee, R, et al. Incidence and phenotype of inflammatory bowel disease from 13 countries in Asia-pacific: results from the Asia-Pacific Crohn's and colitis epidemiologic study 2011–2013. Gastroenterology, 150(suppl 1), 2016, S21.
43. 43 Ng, S, Leung, W, Shi, H, Li, K, Leung, C, Ng, K, Epidemiology of inflammatory bowel disease from 1981–2014: results from a territory-wide population-based registry in Hong Kong. Inflamm Bowel Dis 22 (2016), 1954–1960.
44. 44 Rowe, PG, East Asia modern: shaping the contemporary city, 2005, Reaktion Books, London.
45. 45 National Bureau of Statistics of the People's Republic of China. http://wwwstats.gov.cn/english/, 2012 (accessed Jan 15, 2014).
46. 46 Hu, FB, Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34 (2011), 1249–1257.
47. 47 Benchimol, EI, Guttmann, A, Griffiths, AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 58 (2009), 1490–1497.
48. 48 Bitton, A, Vutcovici, M, Patenaude, V, Sewitch, M, Suissa, S, Brassard, P, Epidemiology of inflammatory bowel disease in Quebec: recent trends. Inflamm Bowel Dis 20 (2014), 1770–1776.
49. 49 Leddin, D, Tamim, H, Levy, AR, Decreasing incidence of inflammatory bowel disease in Eastern Canada: a population database study. BMC Gastroenterol, 14, 2014, 140.
50. 50 Probert, CS, Jayanthi, V, Hughes, AO, Thompson, JR, Wicks, AC, Mayberry, JF, Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 34 (1993), 1547–1551.
51. 51 Benchimol, EI, Mack, DR, Guttmann, A, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol 110 (2015), 553–563.
52. 52 Ng, SC, Tsoi, KK, Kamm, MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis 18 (2012), 1164–1176.
53. 53 Klement, E, Cohen, RV, Boxman, J, Joseph, A, Reif, S, Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 80 (2004), 1342–1352.
54. 54 Ng, SC, Tang, W, Leong, RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 64 (2015), 1063–1071.
55. 55 National Health and Family Planning Commission of the PRC. 2014 report on Chinese resident's chronic disease and nutrition. http://en.nhfpc.gov.cn/2015-06/15/c_45788_2.htm (accessed Oct 19, 2016).
56. 56 Niu, J, Miao, J, Tang, Y, et al. Identification of environmental factors associated with inflammatory bowel disease in a southwestern highland region of China: a nested case-control study. PLoS One, 11, 2016, e0153524.
57. 57 Ananthakrishnan, AN, Cagan, A, Cai, T, et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 13 (2015), 322–329.
58. 58 Hou, JK, Abraham, B, El-Serag, H, Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106 (2011), 563–573.
59. 59 Molodecky, NA, Panaccione, R, Ghosh, S, Barkema, HW, Kaplan, GG, Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis 17 (2011), 1792–1799.
60. 60 Liu, X, Wu, Y, Li, F, Zhang, D, Dietary fiber intake reduces risk of inflammatory bowel disease: result from a meta-analysis. Nutr Res 35 (2015), 753–758.
61. 61 Chassaing, B, Koren, O, Goodrich, JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
62. 62 Ungaro, R, Bernstein, CN, Gearry, R, et al. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol 109 (2014), 1728–1738.
63. 63 Ko, Y, Kariyawasam, V, Karnib, M, et al. Inflammatory bowel disease environmental risk factors: a population-based case-control study of middle eastern migration to Australia. Clin Gastroenterol Hepatol 13 (2015), 1453–1463.
64. 64 Ananthakrishnan, AN, Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12 (2015), 205–217.
65. 65 Bernstein, CN, Wajda, A, Svenson, LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101 (2006), 1559–1568.
66. 66 Gearry, RB, Richardson, AK, Frampton, CM, Dodgshun, AJ, Barclay, ML, Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 25 (2010), 325–333.
67. 67 Soon, IS, Molodecky, NA, Rabi, DM, Ghali, WA, Barkema, HW, Kaplan, GG, The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol, 12, 2012, 51.
68. 68 Luther, J, Dave, M, Higgins, PD, Kao, JY, Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 16 (2010), 1077–1084.
69. 69 Calkins, BM, A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34 (1989), 1841–1854.
70. 70 Jiang, L, Xia, B, Li, J, et al. Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol 41 (2007), 280–284.
71. 71 Coward, S, Clement, F, Williamson, T, et al. The rising burden of inflammatory bowel disease in north America from 2015 to 2025: a predictive model. Am J Gastroenterol, 110(suppl), 2015, S829.
72. 72 Hazlewood, GS, Rezaie, A, Borman, M, et al. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis. Gastroenterology 148 (2015), 344–354.
73. 73 Frolkis, AD, Dykeman, J, Negron, ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145 (2013), 996–1006.
74. 74 Frolkis, AD, Lipton, DS, Fiest, KM, et al. Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studies. Am J Gastroenterol 109 (2014), 1739–1748.
75. 75 Kaplan, GG, Seow, CH, Ghosh, S, et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol 107 (2012), 1879–1887.
76. 76 Colombel, JF, Sandborn, WJ, Reinisch, W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 362 (2010), 1383–1395.
77. 77 Kaplan, GG, Hubbard, J, Panaccione, R, et al. Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease. Arch Surg 146 (2011), 959–964.
78. 78 Bernstein, CN, Nugent, Z, Targownik, LE, Singh, H, Lix, LM, Predictors and risks for death in a population-based study of persons with IBD in Manitoba. Gut 64 (2015), 1403–1411.
79. 79 Bernstein, CN, Wajda, A, Blanchard, JF, The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129 (2005), 827–836.
80. 80 Benchimol, EI, Manuel, DG, Guttmann, A, et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis 20 (2014), 1761–1769.
81. 81 Nguyen, GC, Sheng, L, Benchimol, EI, Health care utilization in elderly onset inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 21 (2015), 777–782.
82. 82 Siegel, CA, Marden, SM, Persing, SM, Larson, RJ, Sands, BE, Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol 7 (2009), 874–881.
83. 83 Long, MD, Kappelman, MD, Pipkin, CA, Nonmelanoma skin cancer in inflammatory bowel disease: a review. Inflamm Bowel Dis 17 (2011), 1423–1427.
84. 84 Wang, Y, Ouyang, Q, Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol 22 (2007), 1450–1455.
85. 85 Zhai, H, Liu, A, Huang, W, et al. Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China. BMC Gastroenterol, 16, 2016, 1.
86. 86 Bodger, K, Kikuchi, T, Hughes, D, Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Aliment Pharm Ther 30 (2009), 265–274.
87. 87 Watts, J, Chen Zhu: from barefoot doctor to China's Minister of Health. Lancet, 372, 2008, 1455.
88. 88 Victoria, CR, Sassak, LY, Nunes, HR, Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol 46 (2009), 20–25.
89. 89 Tozun, N, Atug, O, Imeryuz, N, et al. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol 43 (2009), 51–57.
90. 90 Hammada, T, Lemdaoui, MC, Boutra, F, Zoughailech, D, Asselah, H, Epidemiological aspects of inflammatory bowel disease in an Algerian population. JAHG 5 (2011), 293–302 (in French).